KATZUNG'S BASIC AND
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is participating in a clinical trial for a new medication.
Which action best protects participants while maintaining
ethical research standards?
A. Administer the medication without discussing potential risks
to prevent bias.
B. Ensure participants voluntarily sign informed consent after
receiving understandable information about the study.
C. Exclude participants from asking questions once enrollment
is complete.
D. Share participant information with researchers who are not
involved in the study.
Correct Answer: B
Rationale:
Informed consent requires that participants voluntarily agree to
participate after receiving understandable information
regarding the study's purpose, risks, benefits, alternatives, and
the right to withdraw at any time. This process protects
participant autonomy and is a cornerstone of ethical research.
Option A violates informed consent. Option C restricts
participants' rights. Option D breaches confidentiality.
Question 2
,A nurse is teaching a newly licensed colleague about phases of
medication development. Which statement by the colleague
indicates correct understanding?
A. "Human testing begins after the medication is approved for
public use."
B. "Animal studies are commonly performed before
medications are tested in humans."
C. "All medications tested in animals are eventually approved."
D. "Clinical trials are unnecessary if laboratory testing shows
promising results."
Correct Answer: B
Rationale:
Preclinical testing commonly includes laboratory and animal
studies to evaluate initial safety and biological activity before
human trials begin. Option A is incorrect because human trials
occur before approval. Option C is incorrect because many
drugs fail during development. Option D is incorrect because
human clinical trials remain essential for evaluating safety and
effectiveness.
Question 3
, A nurse caring for a client receiving a newly prescribed
medication understands that the primary purpose of post-
marketing surveillance is to:
A. Determine the medication's chemical structure.
B. Detect rare or long-term adverse effects after widespread
use.
C. Replace preclinical laboratory testing.
D. Eliminate the need for future safety monitoring.
Correct Answer: B
Rationale:
After approval, medications continue to be monitored to
identify uncommon or delayed adverse reactions that may not
have appeared during clinical trials. Option A occurs much
earlier in drug development. Option C is incorrect because post-
marketing surveillance complements rather than replaces
earlier testing. Option D is incorrect because medication safety
monitoring is ongoing.
Question 4
A client asks why a generic medication was substituted for the
prescribed brand-name product. Which response by the nurse
is most appropriate?
CLINICAL PHARMACOLOGY
16TH EDITION
• AUTHOR(S)TODD W.
VANDERAH
TEST BANK
,Question 1
A nurse is participating in a clinical trial for a new medication.
Which action best protects participants while maintaining
ethical research standards?
A. Administer the medication without discussing potential risks
to prevent bias.
B. Ensure participants voluntarily sign informed consent after
receiving understandable information about the study.
C. Exclude participants from asking questions once enrollment
is complete.
D. Share participant information with researchers who are not
involved in the study.
Correct Answer: B
Rationale:
Informed consent requires that participants voluntarily agree to
participate after receiving understandable information
regarding the study's purpose, risks, benefits, alternatives, and
the right to withdraw at any time. This process protects
participant autonomy and is a cornerstone of ethical research.
Option A violates informed consent. Option C restricts
participants' rights. Option D breaches confidentiality.
Question 2
,A nurse is teaching a newly licensed colleague about phases of
medication development. Which statement by the colleague
indicates correct understanding?
A. "Human testing begins after the medication is approved for
public use."
B. "Animal studies are commonly performed before
medications are tested in humans."
C. "All medications tested in animals are eventually approved."
D. "Clinical trials are unnecessary if laboratory testing shows
promising results."
Correct Answer: B
Rationale:
Preclinical testing commonly includes laboratory and animal
studies to evaluate initial safety and biological activity before
human trials begin. Option A is incorrect because human trials
occur before approval. Option C is incorrect because many
drugs fail during development. Option D is incorrect because
human clinical trials remain essential for evaluating safety and
effectiveness.
Question 3
, A nurse caring for a client receiving a newly prescribed
medication understands that the primary purpose of post-
marketing surveillance is to:
A. Determine the medication's chemical structure.
B. Detect rare or long-term adverse effects after widespread
use.
C. Replace preclinical laboratory testing.
D. Eliminate the need for future safety monitoring.
Correct Answer: B
Rationale:
After approval, medications continue to be monitored to
identify uncommon or delayed adverse reactions that may not
have appeared during clinical trials. Option A occurs much
earlier in drug development. Option C is incorrect because post-
marketing surveillance complements rather than replaces
earlier testing. Option D is incorrect because medication safety
monitoring is ongoing.
Question 4
A client asks why a generic medication was substituted for the
prescribed brand-name product. Which response by the nurse
is most appropriate?
